Droperidol is used as
**Core Concept**
Droperidol is a butyrophenone derivative with antipsychotic and antiemetic properties, primarily acting as a dopamine D2 receptor antagonist. This action is responsible for its efficacy in managing conditions such as schizophrenia, nausea, and vomiting.
**Why the Correct Answer is Right**
Droperidol exerts its effects by competitively inhibiting dopamine D2 receptors in the central nervous system. This blockade results in reduced dopaminergic activity, which in turn decreases the excitatory influence on the chemoreceptor trigger zone (CTZ) in the area postrema, thereby reducing nausea and vomiting. Additionally, its antipsychotic effects are attributed to the blockade of dopamine D2 receptors in the mesolimbic pathway, which is involved in the regulation of mood and cognition.
**Why Each Wrong Option is Incorrect**
**Option A:** Droperidol is not a selective serotonin reuptake inhibitor (SSRI), which is a class of antidepressants that act by increasing serotonin levels in the synaptic cleft.
**Option B:** While droperidol does have sedative properties, it is not primarily used as a sedative-hypnotic agent like benzodiazepines.
**Option C:** Droperidol is not a first-generation (typical) antipsychotic, which includes medications like haloperidol that primarily act by blocking dopamine D2 receptors. However, droperidol is a second-generation (atypical) antipsychotic, which has a more complex mechanism of action involving serotonin-dopamine antagonism.
**Clinical Pearl / High-Yield Fact**
Droperidol should be used with caution in patients with cardiovascular disease due to its potential to cause QT interval prolongation, which may increase the risk of torsades de pointes.
**Correct Answer: B. Antiemetic. Droperidol is used as an antiemetic.**